Trial intelligence / Profile preview

Salt Replacement for Metabolic Alkalosis in CF

NCT00163852Phase 3Unknown

Start
Feb 2004
Countries
1
01

Overview

A Phase 3 trial of sodium chloride in cystic fibrosis (CF). Status: unknown.

02

Drugs

sodium chloride
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00163852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00163852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call